Results 1 to 10 of about 522,418 (265)

Use of the SGLT2 inhibitor canagliflozin for control of refractory equine hyperinsulinemia and laminitis [PDF]

open access: yesOpen Veterinary Journal, 2022
Background: Hyperinsulinemia associated with pituitary pars intermedia dysfunction (PPID) and/or equine metabolic syndrome (EMS) is well documented to put horses at high risk of laminitis.
Eleanor M. Kellon, Kathleen M. Gustafson
doaj   +1 more source

Hypertriglyceridemia in equines with refractory hyperinsulinemia treated with SGLT2 inhibitors

open access: yesOpen Veterinary Journal, 2023
Background: Sodium-Glucose CoTransporter-2 [SGLT2] inhibitors, the -flozin group of drugs, which block glucose reuptake in the renal proximal tubule, are being increasingly used off-label to treat horses with refractory hyperinsulinemia. After two years
Eleanor M. Kellon, Kathleen M. Gustafson
doaj   +1 more source

Possible dysmetabolic hyperferritinemia in hyperinsulinemic horses [PDF]

open access: yesOpen Veterinary Journal, 2019
Background: Hyperinsulinemia associated with equine metabolic syndrome (EMS) and pituitary pars intermedia dysfunction (PPID) is a risk factor for laminitis.
Eleanor M. Kellon, Kathleen M. Gustafson
doaj   +1 more source

Clinical analysis of insulin resistance in liver cirrhosis patients

open access: yesShanghai Jiaotong Daxue xuebao. Yixue ban, 2023
Objective·To investigate the insulin resistance in liver cirrhosis patients.Methods·Patients with liver cirrhosis from Xinhua Hospital,Shanghai Jiao Tong University School of Medicine in 2013‒2017 were retrospectively assessed.
SHI Cuicui   +4 more
doaj   +1 more source

Myths about Insulin Resistance: Tribute to Gerald Reaven [PDF]

open access: yesEndocrinology and Metabolism, 2019
Gerald Reaven was often called the “father of insulin resistance.” On the 1-year anniversary of his death in 2018, we challenge three myths associated with insulin resistance: metformin improves insulin resistance; measurement of waist circumference ...
Sun H. Kim, Fahim Abbasi
doaj   +1 more source

DMRT2 Interacts With FXR and Improves Insulin Resistance in Adipocytes and a Mouse Model

open access: yesFrontiers in Endocrinology, 2022
Insulin resistance (IR) plays a critical role in cardiovascular diseases and metabolic diseases. In this study, we identified the downregulation of DMRT2 in adipose tissues from insulin-resistant subjects through bioinformatics analysis and in an insulin-
Jing Tao   +11 more
doaj   +1 more source

A small amount of dietary carbohydrate can promote the HFD-induced insulin resistance to a maximal level. [PDF]

open access: yesPLoS ONE, 2014
Both dietary fat and carbohydrates (Carbs) may play important roles in the development of insulin resistance. The main goal of this study was to further define the roles for fat and dietary carbs in insulin resistance.
Shuang Mei   +10 more
doaj   +1 more source

Regulation of Insulin Clearance by Non-Esterified Fatty Acids

open access: yesBiomedicines, 2022
Insulin stores lipid in adipocytes and prevents lipolysis and the release of non-esterified fatty acids (NEFA). Excessive release of NEFA during sustained energy supply and increase in abdominal adiposity trigger systemic insulin resistance, including in
Sonia M. Najjar   +8 more
doaj   +1 more source

Insulin resistance and insulin sensitizing agents [PDF]

open access: yesMetabolism, 2021
Insulin resistance is a common feature of obesity and type 2 diabetes, but novel approaches of diabetes subtyping (clustering) revealed variable degrees of insulin resistance in people with diabetes. Specifically, the severe insulin resistant diabetes (SIRD) subtype not only exhibits metabolic abnormalities, but also bears a higher risk for ...
Lucia, Mastrototaro, Michael, Roden
openaire   +2 more sources

Acknowledgement to reviewers

open access: yesJournal of Metabolic Health, 2018
No abstract available.
Editorial Office
doaj   +1 more source

Home - About - Disclaimer - Privacy